The other half of the story
Borrelia rarely travels alone. These six tick-borne and stealth pathogens drive much of the chronic, multisystem illness attributed to Lyme — and each has its own research trail and its own country-by-country treatment landscape.
Every card links to a PubMed paper documenting the association.
Intra-erythrocytic parasitization causes hemolysis, especially in asplenic and elderly patients.
PubMed PMID 29893648 →
Severe babesiosis can progress to ARDS and multi-organ failure.
PubMed PMID 22550112 →
Hallmark symptom even in mild infection — disproportionate breathlessness on exertion.
PubMed PMID 22550112 →
Documented complication of severe Babesia infection.
PubMed PMID 22550112 →
Case reports of spontaneous splenic rupture in babesiosis.
PubMed PMID 28486643 →
Acute kidney injury secondary to hemolysis and parasite burden.
PubMed PMID 22550112 →
Symptoms persist for months in immunocompetent and immunocompromised hosts.
PubMed PMID 19035780 →
Leading transfusion-transmitted parasitic infection in the US blood supply.
PubMed PMID 21830968 →
Treatment atlas
First-line acute protocols, chronic / integrative approaches, and clinical notes for the United States, United Kingdom, Germany, Switzerland and Sweden.
| Country | Acute / first-line | Chronic / integrative | Notes |
|---|---|---|---|
🇺🇸United States | Atovaquone + azithromycin 7–10 days (CDC); clindamycin + quinine for severe. | ILADS: atovaquone + azithro 3–6 months; add cryptolepis, artemisinin, methylene blue. | Exchange transfusion for severe parasitemia >10%. |
🇬🇧United Kingdom | Rarely diagnosed; UKHSA refers to specialist tropical disease unit. | Not recognized on NHS — patients self-treat or travel to DE/CH. | Babesia divergens (Europe) is more severe than US strains. |
🇩🇪Germany | Atovaquone + azithromycin per BCA / Klinik St. Georg protocols. | Pulsed combination + whole-body hyperthermia (Babesia is heat-sensitive). | Hyperthermia at 41.6°C considered highly effective for Babesia. |
🇨🇭Switzerland | Atovaquone + azithro per acute infectious disease guidance. | Paracelsus / Swiss Mountain: hyperthermia, ozone, IV artemisinin, methylene blue. | Limited public-system recognition; integrative clinics lead. |
🇳🇱Netherlands | Rarely tested or recognized in public health. | Patients travel to Germany/Belgium or use herbal protocols. | Access to Babesia testing is extremely limited via GP. |
🇸🇪Sweden | Atovaquone + azithromycin when diagnosed (rare). | No chronic treatment in public system; referral abroad common. | Awareness low; Folkhälsomyndigheten data sparse. |